TRB Chemedica Competitors and Similar CompaniesClear all
TRB Chemedica's competitors and similar companies include Repligen, Adamed, Swedish Orphan Biovitrum and Noven Pharmaceuticals.
 TRB Chemedica TRB Chemedica is a company specializing in the production of active pharmaceutical ingredients (APIs), pharmaceutical products, and medical devices. |  Repligen Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems. |  Swedish Orphan Biovitrum Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care. |  Noven Pharmaceuticals Noven Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing, and sale of prescription pharmaceutical products. | ||
Founding Date | Founding Date 1980 | Founding Date 1981 | Founding Date 1986 | Founding Date 2010 | Founding Date 1987 |
Type | Type Private | Type Public | Type Private | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Genève, CH HQ Buenos Aires, AR Biedermannsdorf, AT Campinas, BR Archamps, FR Feldkirchen, DE Sai Ying Pun, HK see more | Locations Waltham, US HQ Shanghai, CN Jüri, EE Castanet Tolosan, FR Ravensburg, DE Bengaluru, IN Waterford, IE see more | Locations Jersey City, US HQ Miami, US | ||
Employees | Employees 900 | Employees 1,78312% decrease | Employees 1,515 | Employees 1,814 | Employees 934 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 7.7 b | Valuation ($) N/A | Valuation ($) 11.1 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $638.8m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) kr22.1b (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $353.9m (FY, 2023) | Cost of goods N/A | Cost of goods kr4.9b (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $284.8m (FY, 2023) | Gross profit N/A | Gross profit kr17.2b (FY, 2023) | Gross profit N/A |
Net income | Net income N/A | Net income $41.6m (FY, 2023) | Net income N/A | Net income kr2.4b (FY, 2023) | Net income N/A |
Operating ⚠ | |||||
Trademarks (US) | Trademarks (US) 2 (Jun, 2020) | Trademarks (US) 12 (FY, 2017) | Trademarks (US) N/A | Trademarks (US) N/A | Trademarks (US) N/A |
For sources of this data, please see the company profile
View Company Profiles
Repligen
HQ
Waltham, US
Employees
1,783↓ 12% decrease
Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems.
View companySwedish Orphan Biovitrum
HQ
Solna, SE
Employees
1,814
Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care.
View companyNoven Pharmaceuticals
HQ
Jersey City, US
Noven Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing, and sale of prescription pharmaceutical products.
View company